May 19, 2020
By Gina Guido-Redden, Co-Founder and COO, Coda Corp USA
The rapid global spread of the coronavirus caught many world governments and health authorities off guard. Gina Guido-Redden, co-founder and COO of Coda Corp USA, offers a comprehensive review of the how the U.S. Food and Drug Administration (FDA) has responded thus far to the pandemic under 21 CFR.
May 14, 2020
By Matt Brawner, Director of Sales Execution, Sequence, and David Jensen, Staff Writer, MasterControl
Complying with the many record and data management requirements for 21 CFR Part 11 and data integrity can be daunting. In this article, Matt Brawner, data integrity subject matter expert (SME) at Sequence Inc., explains how companies can integrate Part 11 and data integrity processes to accelerate pathways to approval and deliver higher quality products to market.
May 14, 2020
By Brandy Chittester, President, IMARC Research
Successful clinical trials are a critical stage in the product life cycle of any life sciences product. Brandy Chittester, president of IMARC Research, outlines how manufacturers can conduct well-controlled trials that meet regulatory compliance and delineates pharmaceutical trials from those of the medical device industry.
May 12, 2020
By Mike Rigert, Staff Writer, MasterControl
Technology and digital transformation are rapidly altering the way medical device manufacturers accelerate production and innovate new products. A new e-book “Mastering Data to Drive Medical Device Innovation to 2030” looks at how the medtech ecosystem is moving toward a more data-centric approach to quality manufacturing. Automated solutions integrated into a digital platform offer device makers the tools to generate real-time intelligence and insights that will lead to greater innovation over the next decade.
May 5, 2020
By David Jensen, Staff Writer, MasterControl
Data is taking on a prominent role in advanced technologies, which is rapidly changing the dynamic of innovation across all industries. A new MasterControl trend brief, “2020 Trends in Quality Data Management and Integrity for the Life Sciences,” examines new life sciences industry trends that pivot around data and how they will impact regulated companies.
April 30, 2020
By Luis Jimenez, Vice President of Business Development, Brandwood CKC
The U.S. Food and Drug Administration's (FDA) 510(k) pathway for medical devices is aimed at simplifying and instilling more predictability in the regulatory process. This article examines 2019 data on manufacturers’ use of the regulatory pathway and looks at some trends and takeaways for device makers.
April 28, 2020
By Dale Thompson, Staff Writer, MasterControl
Your path to quality manufacturing is simple: eliminate paper production records and digitize your shop floor. Follow these steps to achieve results that matter and drive revenue.
April 21, 2020
By James Jardine, GxP Lifeline Editor, MasterControl
Shrinking margins, intensifying competition and rapidly increasing product personalization and customization are complicating new product introduction pipelines in the life sciences. Leveraging the data connectivity capabilities of platforms is the key to overcoming these and other obstructions to a connected quality life cycle.
April 9, 2020
By Angelo Scangas, President and CEO, Quality Support Group (QSG)
A manufacturer’s ability to maintain high-quality products and regulatory compliance depends largely on its suppliers’ own quality-related activities. Leveraged correctly, supplier audits can be an important tool that gives manufacturers greater visibility into these activities, according to Quality Support Group CEO Angelo Scangas.
April 7, 2020
By David Jensen, Staff Writer, MasterControl
The International Organization of Standards (ISO) is a global organization that defines essential requirements for helping businesses improve their products, services and customer relations. Applying these guidelines enables organizations to give their customers the assurance that their products and services are safe, reliable and of good quality. This article introduces the most popular ISO standards and discusses how companies can use them to gain a competitive edge in their markets.
April 2, 2020
By Sarah Beale, Staff Writer, MasterControl
At this point, COVID-19 has touched everyone’s life in some way. While we’re still struggling to keep up with the pandemic, many of our customers are undergoing initiatives to test and/or treat the virus.
March 31, 2020
By Mike Rigert, Staff Writer, MasterControl
In a life sciences industry that highly values risk reduction, Good Automated Manufacturing Practices (GAMP) principles offer key insights on computer validation. GAMP 5 offers companies guidelines that can help ensure greater computer system compliance that reduces risk.
March 26, 2020
By Sarah Beale, Staff Writer, MasterControl
In honor of Leonard Nimoy’s birthday, we’ve taken some of Spock’s words of wisdom and applied them to manufacturing. Because it’s only logical to get paper off the shop floor and fully digitize your processes.
March 24, 2020
By James Jardine, GxP Lifeline Editor, MasterControl
More and more life sciences companies are adopting asset-light models that heavily rely on a broad system of contract organizations. When supply chains expand, however, quality is often the first casualty. Learn the key questions to ask to ensure your system can enforce quality across the entire ecosystem.
March 19, 2020
By Brian Matye, CFO, Regulatory Compliance Associates Inc.
In the life sciences and other regulated industries, effective quality system management is essential. Companies can’t deliver a safe and effective product and comply with regulators without one. But it’s also crucial that companies take a risk-based approach to selecting and developing a quality system that's well suited to their needs. Digital QMS solutions often offer unsurpassed benefits that a paper-based system can’t deliver.
March 17, 2020
By Gina Guido-Redden, Co-Founder and COO, Coda Corp USA
Coronavirus is the newest in a string of natural and man-made disasters and events disrupting the global supply chain. Governments and the private sector need to take a collaborative risk-management approach to planning measures to confront pandemics and other events that threaten the stability of global supply chains and our ability to meet ensuing demand.
March 10, 2020
By Sarah Beale, Staff Writer, MasterControl
Life sciences supply chains are unique. Pharmaceutical and medical device are even more so. Finding out industry standards and how your supply chain can improve are important questions that should be answered by the experts. Gartner recently produced “Supply Chain Benchmarking Data Reveals Differences Between Pharmaceutical and Medical Device Manufacturers” to provide those insights.
March 3, 2020
By David Jensen, Staff Writer, MasterControl
More companies in all industries are migrating to a cloud environment to benefit from the advanced computing power, abundant data storage, and ability to perform complex functions. The cloud provides significant value; however, security has often been a source of concern. This article dispels the five most common myths about cloud security.
February 27, 2020
By Gina Guido-Redden, Co-Founder and COO, Coda Corp USA
Data has massive potential to revolutionize the life sciences for patients, regulators and for manufacturers. Yet at the same time, data integrity remains one of regulatory bodies’ biggest concerns. Learn what you can do to improve your company’s data integrity for regulatory inspections.
February 25, 2020
By Sarah Beale, Staff Writer, MasterControl
The idea behind personalized medicine has always been the goal for health care professionals, but it’s becoming truly achievable with recent advances in technology. For pharmaceutical and medical device companies in the market, here are three trends to help you through 2020.
